全文获取类型
收费全文 | 28615篇 |
免费 | 2050篇 |
国内免费 | 526篇 |
专业分类
耳鼻咽喉 | 97篇 |
儿科学 | 1399篇 |
妇产科学 | 1598篇 |
基础医学 | 3469篇 |
口腔科学 | 227篇 |
临床医学 | 2093篇 |
内科学 | 4517篇 |
皮肤病学 | 436篇 |
神经病学 | 3216篇 |
特种医学 | 358篇 |
外国民族医学 | 4篇 |
外科学 | 2849篇 |
综合类 | 3256篇 |
现状与发展 | 5篇 |
预防医学 | 3135篇 |
眼科学 | 102篇 |
药学 | 2540篇 |
13篇 | |
中国医学 | 825篇 |
肿瘤学 | 1052篇 |
出版年
2023年 | 335篇 |
2022年 | 472篇 |
2021年 | 961篇 |
2020年 | 897篇 |
2019年 | 889篇 |
2018年 | 863篇 |
2017年 | 936篇 |
2016年 | 911篇 |
2015年 | 787篇 |
2014年 | 1369篇 |
2013年 | 2102篇 |
2012年 | 1231篇 |
2011年 | 1482篇 |
2010年 | 1251篇 |
2009年 | 1148篇 |
2008年 | 1231篇 |
2007年 | 1238篇 |
2006年 | 1255篇 |
2005年 | 1039篇 |
2004年 | 905篇 |
2003年 | 857篇 |
2002年 | 744篇 |
2001年 | 670篇 |
2000年 | 616篇 |
1999年 | 495篇 |
1998年 | 420篇 |
1997年 | 455篇 |
1996年 | 449篇 |
1995年 | 394篇 |
1994年 | 397篇 |
1993年 | 349篇 |
1992年 | 351篇 |
1991年 | 344篇 |
1990年 | 355篇 |
1989年 | 282篇 |
1988年 | 227篇 |
1987年 | 213篇 |
1986年 | 237篇 |
1985年 | 296篇 |
1984年 | 275篇 |
1983年 | 159篇 |
1982年 | 219篇 |
1981年 | 198篇 |
1980年 | 178篇 |
1979年 | 148篇 |
1978年 | 132篇 |
1977年 | 111篇 |
1976年 | 89篇 |
1975年 | 63篇 |
1974年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
101.
急性颈脊髓损伤并发抗利尿激素分泌异常综合征的诊断和治疗 总被引:3,自引:0,他引:3
目的探讨急性颈脊髓损伤并发抗利尿激素分泌异常综合征的临床特点、诊断和治疗方法。方法回顾性分析8例急性颈脊髓损伤并发抗利尿激素分泌异常综合征患者的临床资料。脊髓损伤分级:FrankelA级5例,B级3例;损伤节段:C4~53例,C5~63例,C6~72例。8例于受伤后3~7d行骨折椎体次全切除椎管减压、自体髂骨植骨融合及颈椎前路钢板内固定术。3例于术前,5例于术后3~7d发生低钠血症,所有患者低钠血症发生后第2~10d确诊SIADH,根据血钠水平,采用控制每日水量、补钠进行治疗。结果7例经10~21d治愈,血钠平均恢复至138(135~142)mmol/L,血浆渗透压、尿渗透压、尿钠均正常;1例C4骨折、FrankelA级者,因截瘫平面上升并发呼吸衰竭死亡。结论急性颈脊髓损伤并发抗利尿激素分泌异常综合征的发病机制与治疗措施不同于普通低钠血症,早期正确的诊治能降低患者病残率和死亡率,严格控制入液量及补钠为主要治疗方法。 相似文献
102.
目的 探讨LH基因免疫对前列腺增生模型鼠生殖内分泌的影响。方法 RT-PCR法从雌性大鼠垂体细胞中RNA扩增大鼠的促黄体素基因(LH)cDNA片段约(461bp)并克隆至T载体,获得重组质粒T-LH,限制酶酶切,酶连接,构建PCDNA3.1(-)/HbsAg/LH,经脂质体转染纯化的重组质粒至COS细胞中,通过肌肉注射构建的PCDNA3.1(-)/HbsAg/LH与前列腺增生大鼠,2个月内给药两次。结果 体外培养COS细胞,发现HBsAg与LH连接物表达较好,肌肉注射前列腺增生模型鼠重组质粒后,模型鼠LH与T的含量明显低于对照组。结论 PCDNA3.1(-)/HbsAg/LH可参与前列腺增生模型鼠生殖内分泌腺的调节。 相似文献
103.
前列腺癌去势术前后雄性激素变化的研究 总被引:7,自引:1,他引:6
目的 :观察前列腺癌去势术前后雄性激素的变化。 方法 :16例前列腺癌病人在手术前后分别采集血清样本 ,用放射免疫法测定睾酮 (T)、游离睾酮 (FT)、双氢睾酮 (DHT)的含量 ,进行对比分析。 结果 :手术前后 ,血清中T、FT、DHT浓度有非常明显的差异 ,手术后分别下降 92 .2 7%、92 .2 6%、5 8.3 6% ,以T、FT下降为主。根据 2次测定的结果采用配对t检验方法 ,P <0 .0 0 1。 结论 :去势术后 ,去除了血清中绝大部分T、FT ,而DHT仅下降5 8.3 6% ,应当继续使用雄性激素受体竞争剂 ,阻止残存的雄性激素作用 相似文献
104.
生长激素抗肝纤维化的作用及其机制 总被引:3,自引:0,他引:3
目的 探讨重组人生长激素 (rhGH)对肝硬化大鼠在肝功能、门静脉高压等方面的治疗作用及其可能的机制。方法 雄性SD大鼠建立肝硬化模型 ,随机分组 ,分别给予NS、rhGH (333ng/KgBW ,ip ,qd× 7d)处理。 结果 rhGH处理前后肝硬化肝组织GHR的配体结合容量 [fmol/mg ,(31± 4 )vs .(4 0± 7) ]及其mRNA量 (iOD ,pixel)均显著升高 (2 3± 3)vs.(4 2± 8) ;P <0 0 5 ,肝硬化大鼠血清白蛋白 (g/L )显著升高 (2 9± 4 )vs .(37± 7) ;P <0 0 5、ALT活性 (U/L)显著降低 (89± 15 ,6 9± 7;P <0 0 5 ) ,肝硬化肝组织丙二醛含量 (nmol/mg)显著降低 (18 7± 3 2 ,12 0± 2 2 ;P <0 0 5 )、超氧化物歧化酶活性 (U/mg)显著升高 (82 4± 10 8,10 2 9± 76 ;P <0 0 5 )、胶原纤维相对含量 (% )显著降低 (2 2 30± 3 86vs.14 70± 2 0 7;P <0 0 5 ) ,肝硬化大鼠的门静脉压 (cmH2 O)亦显著降低 (14 4± 2 0vs.9 3± 1 5 ;P <0 0 5 )。结论 药理剂量的rhGH能够促进肝硬化大鼠的白蛋白合成、改善肝细胞功能 ,有助于抑制肝组织纤维化、缓解门静脉压力。 相似文献
105.
G
NÜL
CAL MERIH BERBEROGLU SEMA AKURN NIHAL MEMOGLU AYDAN KNCOGULLARI 《Pediatrics international》1995,37(1):7-11
A total of 54 previously untreated patients (15 girls, 39 boys) with poor growth due to idiopathic growth hormone deficiency (IGHD) were treated with human growth hormone (hGH), continuously up to 4 years. All of the patients had a peak hGH level which was below 10 ng/mL after at least two pharmacological tests and/or blunted physiologic hGH secretion, and their height was below ?2.5 s.d. for age and gender. After the 1st year of therapy, height velocity (HV) increased significantly when compared with baseline (from 3.18 ±0.76 cm/year to 9.17±1.03 cm/year; P <0.001), declined during the 2nd year and then remained significantly higher than pretreatment HV. When considering improvement in height expressed by height standard deviation score (SDS), during the therapy all of the patients showed a significant gain ± 1.72±1.09 (from ?4.11±0.61 to ?2.21±0.48). The height values were significantly higher than pretreatment, but remained below ?2 s.d. after 4 years of hGH therapy in our patients. Increased height velocity has been sustained, but height improvement after therapy was inversely correlated to height SDS for chronological age of patients at the start of therapy. In conclusion post-treatment height has been shown to be related to height deficit at the beginning of therapy. Therapy was well tolerated with no local or systemic adverse effects or acceleration of bone age. 相似文献
106.
对生长激素缺乏症(GHD)患儿生长激素(GH)治疗前后的免疫功能改变进行了观察。结果显示:(1)GHD患儿NK细胞活性明显降低,经GH治疗3个月后恢复到正常水平;(2)GHD患儿治疗前IL-1a和IL-2活性偏低,治疗后两者有逐渐增高的趋势;(3)治疗前后CD细胞亚群、sIL-2R和LPS诱生的TNFa含量均无明显变化。认为GH缺乏症患儿存在一定的免疫功能缺陷,而GH有调节其免疫功能的作用。 相似文献
107.
M. DAHLSTROM M. ESBJ
RNSSON LILJEDAHL J. GIERUP L. KAIJSER E. JANSSON 《Acta physiologica (Oxford, England)》1997,160(1):49-55
A previous study showed that adult female dancers have a high percentage of type I fibres in vastus lateralis. similar to that of endurance-trained female runners ar female cross-country skiers. It is not known if dancers already at an early age are characterized by a high percentage of type I fibres or develop a high percentage of type I fibres as a consequence of dance training. Furthermore. the muscle fibre composition of male dancers has not previously been studied. Therefore the aim of the study was to analyse skeletal muscle fibre characteristics in 10-year-old and 20-year-old dancers of both sexes. Age-matched boys and girls whose physical activity was average for their age groups served as controls. Muscle biopsies for histochemical analysis were obtained from vastus lateralis using the percutaneous needle technique. The major finding of the present study was that the vastus lateralis of young dancers of both sexes had a higher percentage of type I fibres than that of controls. Moreover. the higher type I percentage was seen not only in 20 year aids. but also in 10 year aids. who had begun their dance training at a professional level only a few weeks earlier. No significant difference in this respect was found between female and male dancers. In conclusion. the muscle fibre type composition in young dancers of both sexes differs from that of the average individual of the same age and is characterized by a high percentage of type I fibres. 相似文献
108.
109.
Seishi Inoue Tadayasu Shono Mieko Shono Masayuki Azuma Toshiaki Hirabayashi Oshi Inagaki Hidetaro Mori Yoshikazu Fujita 《Journal of bone and mineral metabolism》1990,8(3):19-23
A case of polycythemia vera complicated by chronic renal failure under maintenance hemodialysis requiring parathyroidectory
(PTH) for secondary hyperparathyroidism (2° HPT) is reported.
A 62 year old female presented with 75000 white blood cells (WBC)/μl, 703×104 red blood cells (RBC)/μl, 23×104 platelets (PLT)/μl, hyperuricemia and hypertension in 1970 and the diagnosis of polycythemia vera was made. Hemodialysis
was started in October 1974 for chronic renal failure. Blood cells in peripheral blood rapidly decreased in number after the
beginning of dialysis, reaching the level of 10000∼20000 WBC/μl, and 150∼250×104RBC/μl. In August 1988, marked bone resorption in X-ray picture and high serum alkaline phosphatase and parathyroid hormone
(PTH) noted along with 17400 WBC/μl, 370×104RBC/μl and 35.9×104PLT/μl.
After subtotal PTX removing 3.21g parathyroid gland, serum PTH rapidly fell. At 3 months after PTX, WBC rose to 23600/μl,
RBC 372×104/μl and PLT 94.0×104/μl. At 6 months, WBC was to 31000/μl, RBC 429×104/μl and PLT 78.0×104/μl, suggesting an inhibitory action of PTH on not only RBC, but also WBC and PLT. 相似文献
110.
SRY基因诊断在临床中的应用 总被引:1,自引:0,他引:1
应用聚合酶链式反应(PCR)扩增技术,对10例染色体核型为46,XY和1例为46,XX/46,XY的性反转、睾丸女性化、两性畸形及男性生殖器发育不良的患者进行了性别决定区(SRY)基因检测。结果表明9例46,XY和1例46,XX/46,XY患者的SRY基因存在,1例46,XY女性患者的SRY基因缺失。该结果表明能够用分子生物学技术对性反转、性发育异常的病因进行分析 相似文献